Paris, 9 April 2026 – The Company's shareholders are invited to participate in the Annual General Meeting (AGM), which will be held on Wednesday 29 April 2026, at 10:00 am, at Altamir's offices: 61 ...

OMER-DECUGIS & CIE - Omer-Decugis and Cie strengthens its Executive Committee to support its 2030 growth ambitions ...

GROUPE PLASTIVALOIRE - Implementation of the project to transfer the listing of Plastivaloire Group shares to the Euronext Growth market ...

The Extraordinary General Meeting held on 31 March 2026 has approved the redemption of issue premium treated as paid-up capital, for an amount of EUR 0.05 per share. In accordance with Article 7:209 ...

EPC GROUPE - EPC Groupe joins the United Nations Global Compact and reinforces its commitment to responsible and sustainable growth ...

Paris, 8 April 2026, 6 :30 pm - Ecoslops, the cleantech company that brings oil into the circular economy, announces its results for the fiscal year ended 31 December 2025, as approved by the Board of ...

Arcure, an edge AI computer vision technology leader for industrial safety, is announcing its annual results for the year ended December 31, 2025, approved by the Board of Directors. Arcure continued ...

April 7, 2026 – 6:00 pm – Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 – ALDMS), a specialist in high-performance medical imaging systems for digital radiology and bone densitometry ...

PM CET - Oxurion NV (Euronext Brussels: OXUR), a pharmaceutical outsourcing company based in Leuven, today made the following announcement regarding the financial calendar: Due to administrative ...

No 596/2014 as it applies in the UK (the Market Abuse Regulation), full details of the transactions, in aggregated and detailed form, are available at Coca-Cola Europacific Partners is one of the ...

April 2026 - 6.00 pm - Lhyfe (Euronext Paris - FR0014009YQ1 - LHYFE), an independent green hydrogen producer for low carbon industry and mobility, informs to the total number of shares and voting ...

Strong sales growth, expansion of the customer portfolio and BioSolutions, and strengthening of the financial structure thanks to Huvepharma ...